1. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175:367-416. PMID:
17277290.
2. Maoz C, Shitrit D, Samra Z, Peled N, Kaufman L, Kramer MR, et al. Pulmonary
Mycobacterium simiae infection: comparison with pulmonary tuberculosis. Eur J Clin Microbiol Infect Dis 2008;27:945-950. PMID:
18488259.
3. Velayati AA, Farnia P, Mozafari M, Malekshahian D, Seif S, Rahideh S, et al. Molecular epidemiology of nontuberculous mycobacteria isolates from clinical and environmental sources of a metropolitan city. PLoS One 2014;9:e114428PMID:
25485795.
4. van Ingen J, Boeree MJ, Dekhuijzen PN, van Soolingen D. Clinical relevance of Mycobacterium simiae in pulmonary samples. Eur Respir J 2008;31:106-109. PMID:
18166593.
5. Wang HY, Bang H, Kim S, Koh WJ, Lee H. Identification of
Mycobacterium species in direct respiratory specimens using reverse blot hybridisation assay. Int J Tuberc Lung Dis 2014;18:1114-1120. PMID:
25189562.
6. Ben Salah I, Adekambi T, Raoult D, Drancourt M. rpoB sequence-based identification of
Mycobacterium avium complex species. Microbiology 2008;154:3715-3723. PMID:
19047739.
7. Frothingham R, Wilson KH. Sequence-based differentiation of strains in the
Mycobacterium avium complex. J Bacteriol 1993;175:2818-2825. PMID:
8491701.
8. Turenne CY, Tschetter L, Wolfe J, Kabani A. Necessity of quality-controlled 16S rRNA gene sequence databases: identifying nontuberculous
Mycobacterium species. J Clin Microbiol 2001;39:3637-3648. PMID:
11574585.
9. Adekambi T, Colson P, Drancourt M. rpoB-based identification of nonpigmented and late-pigmenting rapidly growing mycobacteria. J Clin Microbiol 2003;41:5699-5708. PMID:
14662964.
10. Clinical Laboratory Standards Institute. CLSI document No. M24-A2. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard. 2nd ed. Wayne: Clinical Laboratory Standards Institute; 2011.
11. Meier A, Heifets L, Wallace RJ Jr, Zhang Y, Brown BA, Sander P, et al. Molecular mechanisms of clarithromycin resistance in
Mycobacterium avium: observation of multiple 23S rDNA mutations in a clonal population. J Infect Dis 1996;174:354-360. PMID:
8699066.
12. El Sahly HM, Septimus E, Soini H, Septimus J, Wallace RJ, Pan X, et al.
Mycobacterium simiae pseudo-outbreak resulting from a contaminated hospital water supply in Houston, Texas. Clin Infect Dis 2002;35:802-807. PMID:
12228816.
13. Baghaei P, Tabarsi P, Farnia P, Marjani M, Sheikholeslami FM, Chitsaz M, et al. Pulmonary disease caused by
Mycobacterium simiae in Iran's national referral center for tuberculosis. J Infect Dev Ctries 2012;6:23-28. PMID:
22240424.
14. van Ingen J, Totten SE, Heifets LB, Boeree MJ, Daley CL. Drug susceptibility testing and pharmacokinetics question current treatment regimens in
Mycobacterium simiae complex disease. Int J Antimicrob Agents 2012;39:173-176. PMID:
22099521.
15. van Ingen J, van der Laan T, Dekhuijzen R, Boeree M, van Soolingen D.
In vitro drug susceptibility of 2275 clinical nontuberculous
Mycobacterium isolates of 49 species in The Netherlands. Int J Antimicrob Agents 2010;35:169-173. PMID:
20006470.